AB Science Valuation
| ABSCF Stock | USD 1.45 0.18 14.17% |
Based on Macroaxis valuation methodology, the entity appears to be undervalued. AB Science SA owns a latest Real Value of $1.6 per share. The recent price of the entity is $1.45. Our model approximates the value of AB Science SA from evaluating the entity fundamentals such as Operating Margin of (12.22) %, shares owned by institutions of 2.01 %, and Price To Earning of (13.81) X as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that AB Science's price fluctuation is unstable at this time. Calculation of the real value of AB Science SA is based on 3 months time horizon. Increasing AB Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ABSCF pink sheet is determined by what a typical buyer is willing to pay for full or partial control of AB Science SA. Since AB Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ABSCF Pink Sheet. However, AB Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.45 | Real 1.6 | Hype 1.45 | Naive 1.54 |
The real value of ABSCF Pink Sheet, also known as its intrinsic value, is the underlying worth of AB Science SA Company, which is reflected in its stock price. It is based on AB Science's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AB Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AB Science SA helps investors to forecast how ABSCF pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AB Science more accurately as focusing exclusively on AB Science's fundamentals will not take into account other important factors: AB Science Total Value Analysis
AB Science SA is presently forecasted to have takeover price of 449.58 M with market capitalization of 421.75 M, debt of 6.69 M, and cash on hands of 7.64 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AB Science fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
449.58 M | 421.75 M | 6.69 M | 7.64 M |
AB Science Investor Information
About 41.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.32. AB Science SA had not issued any dividends in recent years. The entity had 1000:1 split on the 31st of December 2009. Based on the measurements of operating efficiency obtained from AB Science's historical financial statements, AB Science SA is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.AB Science Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AB Science has an asset utilization ratio of 7.55 percent. This implies that the Company is making $0.0755 for each dollar of assets. An increasing asset utilization means that AB Science SA is more efficient with each dollar of assets it utilizes for everyday operations.AB Science Ownership Allocation
AB Science SA secures a total of 46.86 Million outstanding shares. AB Science SA shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.AB Science Profitability Analysis
The company reported the revenue of 1.61 M. Net Loss for the year was (14.46 M) with profit before overhead, payroll, taxes, and interest of 1.5 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AB Science's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AB Science and how it compares across the competition.
About AB Science Valuation
The pink sheet valuation mechanism determines AB Science's current worth on a weekly basis. Our valuation model uses a comparative analysis of AB Science. We calculate exposure to AB Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AB Science's related companies.AB Science S.A., a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was incorporated in 2001 and is headquartered in Paris, France. Ab Science operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.
8 Steps to conduct AB Science's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AB Science's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AB Science's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AB Science's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AB Science's revenue streams: Identify AB Science's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AB Science's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AB Science's growth potential: Evaluate AB Science's management, business model, and growth potential.
- Determine AB Science's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AB Science's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
AB Science Growth Indicators
Investing in growth stocks can be very risky. If the company such as AB Science does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 46.9 M | |
| Shares Float | 27.5 M |
Complementary Tools for ABSCF Pink Sheet analysis
When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |